Caricamento...
Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer
Lung cancer is the leading cause of cancer-related deaths, demanding improvement in current treatment modalities to reduce the mortality rates. Lung cancer is divided into two major classes with non-small cell lung cancer representing ~84% of lung cancer cases. One strategy widely used to treat non-...
Salvato in:
| Pubblicato in: | Biochem Pharmacol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854807/ https://ncbi.nlm.nih.gov/pubmed/32681833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2020.114154 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|